ILMN
Illumina, Inc.NASDAQHealthcare$127.38+0.59%ClosedMarket Cap: $19.48B
As of 2026-04-06
Valuation
P/E (TTM)
22.91
PEG
0.14
P/B
7.16
P/S
4.49
EV/EBITDA
14.15
DCF Value
$-59.86
FCF Yield
4.8%
Div Yield
0.0%
Margins & Returns
Gross Margin
66.5%
Operating Margin
19.9%
Net Margin
19.6%
ROE
34.9%
ROA
16.0%
ROIC
12.0%
Income Statement
| Period | Revenue | Gross Margin | Operating Income | Net Income | EPS | Dividend |
|---|---|---|---|---|---|---|
| Q4 2025 | $1.16B | 67.0% | $256.0M | $334.0M | $2.16 | — |
| FY 2025 | $4.34B | 66.5% | $865.0M | $850.0M | $5.44 | — |
| Q3 2025 | $1.08B | 67.6% | $231.0M | $150.0M | $0.97 | — |
| Q2 2025 | $1.06B | 65.6% | $214.0M | $235.0M | $1.49 | — |
| Q1 2025 | $1.04B | 65.6% | $164.0M | $131.0M | $0.82 | — |
| Q4 2024 | $1.10B | 65.9% | $202.0M | $187.0M | $1.17 | — |
| FY 2024 | $4.37B | 65.4% | $-833.0M | $-1.22B | $-7.69 | — |
| Q3 2024 | $1.08B | 69.0% | $741.0M | $705.0M | $4.41 | — |
| Q2 2024 | $1.11B | 64.8% | $-1.64B | $-1.99B | $-12.50 | — |
| Q1 2024 | $1.08B | 62.0% | $-111.0M | $-126.0M | $-0.79 | — |
| Q4 2023 | $1.12B | 60.1% | $-164.0M | $-175.0M | $-1.11 | — |
| FY 2023 | $4.50B | 60.9% | $-1.07B | $-1.16B | $-7.35 | — |